These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16690522)

  • 41. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
    Anderson T; Bender RA; Fisher RI; DeVita VT; Chabner BA; Berard CW; Norton L; Young RC
    Cancer Treat Rep; 1977 Sep; 61(6):1057-66. PubMed ID: 71205
    [No Abstract]   [Full Text] [Related]  

  • 42. DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL).
    Coleman M; Leonard J; Shuster MW; Kaufman TP
    Eur J Haematol Suppl; 2001 Jul; 64():41-5. PubMed ID: 11486401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A preliminary study of chemo-interferon therapy in malignant lymphoma].
    Takeyama H; Yano K; Fukutani H; Watanabe E
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):140-5. PubMed ID: 3800402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas.
    Fisher RI; Kaminski MS; Wahl RL; Knox SJ; Zelenetz AD; Vose JM; Leonard JP; Kroll S; Goldsmith SJ; Coleman M
    J Clin Oncol; 2005 Oct; 23(30):7565-73. PubMed ID: 16186600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
    O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
    J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
    Spies SK; Snyman HW
    S Afr Med J; 1966 Dec; 40(44):1061-4. PubMed ID: 5334208
    [No Abstract]   [Full Text] [Related]  

  • 48. [Erythema nodosum association with malignant lymphoma].
    Pileckyte M; Griniūte R
    Medicina (Kaunas); 2003; 39(5):438-42. PubMed ID: 12794364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-agent therapy for Hodgkin's disease.
    Carter SK; Livingston RB
    Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
    [No Abstract]   [Full Text] [Related]  

  • 50. Complete remission after repeated trofosfamide treatment in relapsing high-grade malignant non-Hodgkin's lymphoma--a case report.
    Norum J
    Acta Oncol; 1994; 33(7):831. PubMed ID: 7993654
    [No Abstract]   [Full Text] [Related]  

  • 51. Trofosfamide is effective in refractory non-Hodgkin's lymphoma.
    Salminen E; Nikkanen V; Lindholm L
    Eur J Cancer; 1995 Dec; 31A(13-14):2419-20. PubMed ID: 8652284
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients.
    Asfour IA; El Shazly S; Fayek MH; Hegab HM; Raouf S; Moussa MA
    Biol Trace Elem Res; 2006 Apr; 110(1):19-32. PubMed ID: 16679545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation and role of single chemotherapeutic agents in adult non-Hodgkin's lymphoma.
    Davis HL; von Hoff DD
    Recent Results Cancer Res; 1978; 65():129-44. PubMed ID: 746243
    [No Abstract]   [Full Text] [Related]  

  • 54. Chemotherapy of lymphomas.
    Sage RE
    Australas Radiol; 1974 Dec; 18(4):383-6. PubMed ID: 4462539
    [No Abstract]   [Full Text] [Related]  

  • 55. Could protein kinase inhibitors become a next generation pharmacotherapy for non-Hodgkin's lymphoma?
    Cohen M; Graf SA
    Expert Opin Pharmacother; 2024 Apr; 25(6):637-640. PubMed ID: 38726844
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacogenetics and proteomics of anticancer drugs in non-Hodgkin's lymphoma.
    Loni L; De Braud F; Zinzani PL; Danesi R
    Leuk Lymphoma; 2003; 44 Suppl 3():S115-22. PubMed ID: 15202534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New molecular targets for treatment of lymphoma.
    Pro B; Younes A
    Curr Oncol Rep; 2004 Sep; 6(5):360-8. PubMed ID: 15291979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of the therapeutic effectiveness of likurim in lymphosarcoma in dogs].
    Kliuchanskaia NV; Iliukhin AV; Kiselev AV
    Gematol Transfuziol; 1984 Aug; 29(8):46-9. PubMed ID: 6548198
    [No Abstract]   [Full Text] [Related]  

  • 59. Cytostatic influence of thioproline on peripheral lymphocytes of healthy persons and non-Hodgkin's lymphoma patients.
    Rozmysłowicz T
    Haematol Blood Transfus; 1989; 32():127-30. PubMed ID: 2560444
    [No Abstract]   [Full Text] [Related]  

  • 60. Hodgkin's disease and fatty liver.
    Clingan PR; McCarthy J
    Aust N Z J Med; 1986 Aug; 16(4):515. PubMed ID: 3467696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.